Synthetic transcription factor engineering for cell and gene therapy
Trends in Biotechnology · 2024-04 · 42 (4) · 449-463
DOI: 10.1016/j.tibtech.2023.09.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2024-04. Verfasst von Bhoomi Bhatt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, and Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Transcription Factors, Gene Expression Regulation. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 120 Literaturangaben.
Abstract (Originalsprache)
Synthetic transcription factors (synTFs) that control beneficial transgene expression are an important method to increase the safety and efficacy of cell and gene therapy. Reliance on synTF components from non-human sources has slowed progress in the field because of concerns about immunogenicity and inducer drug properties. Recent advances in human-derived DNA-binding domains (DBDs) and transcriptional activation domains (TADs) paired with novel control modules responsive to clinically approved small molecules have poised the synTF field to overcome these hurdles. Advances include controllers inducible by autonomous signaling inputs and more complex, multi-input synTF circuits. Demonstrations of advanced control strategies with human-derived transcription factor components in clinically relevant vectors and in vivo models will facilitate progression into the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, and Baylor College of Medicine, Houston, TX, USA.
- Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, and Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Housto…
Zitieren
APA
Bhatt, B., García-Díaz, P., & Foight, G. W. (2024). Synthetic transcription factor engineering for cell and gene therapy. Trends in Biotechnology, 42(4), 449-463. https://doi.org/10.1016/j.tibtech.2023.09.010
Vancouver
Bhatt B, García-Díaz P, Foight GW. Synthetic transcription factor engineering for cell and gene therapy. Trends in Biotechnology. 2024;42(4):449-463. doi:10.1016/j.tibtech.2023.09.010
BibTeX
@article{Bhatt2024,
author = {Bhatt, Bhoomi and García-Díaz, Pablo and Foight, Glenna Wink},
title = {Synthetic transcription factor engineering for cell and gene therapy},
journal = {Trends in Biotechnology},
year = {2024},
volume = {42},
number = {4},
pages = {449--463},
doi = {10.1016/j.tibtech.2023.09.010}
}
EUVIMED